FORWARD PHARMA A/S

(FWP)
Delayed Nasdaq  -  04:00 2022-08-09 pm EDT
3.660 USD   -4.19%
08/05European ADRs Move Lower in Friday Trading
MT
08/04European ADRs Move Higher in Thursday Trading
MT
07/14European ADRs Tumble Lower in Thursday Trading
MT
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Lower in Thursday Trading

06/23/2022 | 11:08am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AKARI THERAPEUTICS, PLC 8.39% 1.55 Delayed Quote.3.33%
BARCLAYS PLC -0.08% 165.86 Delayed Quote.-11.30%
BICYCLE THERAPEUTICS PLC -2.89% 26.85 Delayed Quote.-55.89%
BIONTECH SE -7.14% 157.21 Delayed Quote.-39.02%
CELLECTIS S.A. -9.83% 3.21 Real-time Quote.-56.85%
CREDIT SUISSE GROUP AG -3.39% 5.186 Delayed Quote.-39.50%
DEUTSCHE BANK AG -0.82% 8.727 Delayed Quote.-20.79%
ERYTECH PHARMA S.A. 4.27% 1.27 Real-time Quote.-40.09%
FORWARD PHARMA A/S -4.19% 3.66 Delayed Quote.-38.69%
LLOYDS BANKING GROUP PLC -0.54% 44.995 Delayed Quote.-5.87%
MEREO BIOPHARMA GROUP PLC -0.85% 1.17 Delayed Quote.-26.88%
NATUZZI S.P.A. -4.54% 7.3029 Delayed Quote.-54.16%
NUCANA PLC -1.89% 1.56 Delayed Quote.-34.45%
VERONA PHARMA PLC 44.32% 10.03 Delayed Quote.49.26%
VOXELJET AG -1.98% 4.5283 Delayed Quote.-23.25%
WPP PLC -2.30% 798 Delayed Quote.-28.72%
All news about FORWARD PHARMA A/S
08/05European ADRs Move Lower in Friday Trading
MT
08/04European ADRs Move Higher in Thursday Trading
MT
07/14European ADRs Tumble Lower in Thursday Trading
MT
07/11European ADRs Move Lower in Monday Trading
MT
07/08European ADRs Move Slightly Higher in Friday Trading
MT
07/07FORWARD PHARMA A/S : Receipt of Tax Audit Report - Form 6-K
PU
07/01European ADRs Fall Sharply in Friday Trading
MT
06/30European ADRs Fall Sharply in Thursday Trading
MT
06/28European ADRs Nudge Lower in Tuesday Trading
MT
06/23European ADRs Move Lower in Thursday Trading
MT
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -1,89 M - -
Net cash 2021 70,8 M - -
P/E ratio 2021 -22,0x
Yield 2021 -
Capitalization 26,0 M 26,0 M -
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees 4
Free-Float 6,85%
Chart FORWARD PHARMA A/S
Duration : Period :
Forward Pharma A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FORWARD PHARMA A/S
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Claus Bo Svendsen CEO & Principal Financial Officer
Florian Schönharting Director
Grant Hellier Lawrence Independent Director
Duncan Charles Mcnaught Moore Independent Director
Torsten Rüdiger Goesch Director
Sector and Competitors
1st jan.Capi. (M$)
FORWARD PHARMA A/S-38.69%27
GILEAD SCIENCES, INC.-14.61%77 266
VERTEX PHARMACEUTICALS36.08%75 386
REGENERON PHARMACEUTICALS, INC.-1.48%67 420
BIONTECH SE-39.02%41 143
WUXI APPTEC CO., LTD.-20.94%40 375